AveXIS Announcement
The University of Utah and The Utah Program for Inherited Neuromuscular Disorders (UPIN) are announced as one of the 26 sites across 13 countries to be conducting the AveXis SMA trial with pre-symptomatic SMA Types 1, 2, and 3 patients. Read more about the trial and the first patient dosed HERE.
